Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT01831427 · COMPLETED
Trial details
- NCT number
- NCT01831427
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-28
- Primary completion
- 2015-01-05
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.